Wednesday, September 30, 2020
Home Life Style Health & Fitness Chinese Alzheimer's Drug to Undergo Global Clinical Trials

Chinese Alzheimer’s Drug to Undergo Global Clinical Trials

In the last test, a total of 818 participants from 34 leading hospitals in China took 450 mg GV-971 orally twice a day for a treatment period of nine months, which proved safe and effective in improving cognition

An innovative Chinese Alzheimer’s drug extracted from brown algae is set to go through clinical trials on 2,000 patients overseas this year.

The orally administered drug GV-971 will be tested in 200 clinical centers in North America, the European Union, Eastern Europe, Asia Pacific and other places, according to Green Valley Pharmaceutical Company, one of the drug’s co-developers.

China has already approved the drug.

Green Valley Pharmaceutical will complete the global clinical trials in 2024 and submit the New Drug Application to the US Food and Drug Administration and European Medicines Agency in 2025, Xinhua reported.

GV-971 was jointly developed by the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences (CAS), Ocean University of China and Green Valley, after a 22-year study.

Alzheimer's
A lady suffering from Alzheimer’s. Flickr

The results of the mechanism of action study were published in the international journal Cell Research in September 2019, saying that the drug works by modifying gut bacteria to ultimately reduce brain inflammation in mice that were genetically engineered to have the disease.

It was approved for marketing last November by China’s National Medical Products Administration, which said the GV-971 “can improve cognition in patients with mild to moderate Alzheimer’s disease (AD).”

Also Read: NASA Loses Contact with Satellite to Study Distant Planets: Report

According to researchers, apart from animal experiments, more than 1,100 Chinese Alzheimer’s disease patients participated in clinical trials before the drug hit the market.

In the last test, a total of 818 participants from 34 leading hospitals in China took 450 mg GV-971 orally twice a day for a treatment period of nine months, which proved safe and effective in improving cognition.

“Because of its effectiveness on Chinese patients, we expect this drug to benefit more people in the rest of the world,” said Lyu Songtao, Chairman of the Shanghai-based pharmaceutical company. (IANS)

STAY CONNECTED

19,133FansLike
362FollowersFollow
1,779FollowersFollow

Most Popular

Jewelry: An Investment and a Sentiment

After a tough six months of pandemic (and continuing) wherein most of us were resigned to our homes and restrained ourselves from socializing, finally...

Is There Greater Risk of Heart Disease to Men than Women?

Over the years, multiple researchers have concluded that heart disease impacts men and women differently. It has been noted that in the younger age...

Knowing the Basics of Your Sneaker Shoes

Sneaker Shoes have taken over the world and how! Understandably so, because who would do not want to sport footwear that is not only...

Fusion Taking Over in Indian Kitchens

Owing to the pandemic, food consumption has become a cautious habit and people are highly conscious of what they are eating and where it...

Sean Toy Provides Rudimentary Overview of Nutrition

Nutrition makes up the second half of the exercise equation, with work and effort being the other, yet many who are committed to consistently...

Reviewing the Song ‘Bol re Dilli Bol’ by Kailash Kher

BY RADHIKA TANDON The song Bol re Dilli Bol, vocalized by Kailash Kher, is indeed a thought-provoking song that leaves you gutted to your core....

How To Become An Influencer On Angel Amplifiers

Marketing techniques and strategies are changing. With the advent of the digital age, brands and companies are also evolving, cruising towards online marketing. This...

Virtual ‘Deepotsav’ in Ayodhya Instead of Ram Lila

The Ayodhya administration has denied permission for Ram Lila in Ayodhya due to the coronavirus pandemic, however, the administration has started preparations to organize...

Recent Comments